| http://www.w3.org/ns/prov#value | - Fitch believes Pfizer's sharpening strategic focus on human branded pharmaceuticals, while decreasing the diversity of its product portfolio, will enable the company to improve the productivity of its core operations, including research & development, marketing and manufacturing.
|
